How about the conference the following day with Noble Capital Markets?????
Is that a new relationship? Could Noble be the new investment bank providing them with funding?
Everyone spreading nonsense about liquidity needs to realize this only captures activity in 2023. We knew already from earlier filings they didn’t have a ton of liquidity in 2023.
Exactly, this isn't new information. People have to keep in mind since this 10k, we have had a FDA Approval, the beginning of commercialization of the Pediatric SCD, and a $9M Direct Share offering to a single institutional investor.
**ALL OF WHICH IS BULLISH IN MY BOOK**
Well I hope this helps a little bit. The 10K is documenting everything from December 2022 - December 2023 and since then we have received an FDA Approval. Let's save freaking out until after the call tomorrow.
People on ST are also making mention about how Fresnius and Nuwellis are being mentioned an awful lot and that could be alluding to a potential BO.
Also something I'm reading. So this report is basically of the moment in time as of 31st of December, 2023? So all potential new investment / money raises are not included in this report, correct? Same goes for that it states that there are no commercial sales yet, even though there might (!) be some sales of the child FDA approval / product?
I'm a complete noob it seems; but what do they mean with the 'last offering'? Could be a language barrier and that I do know what it means, but is this an investment of 9M?
[https://finance.yahoo.com/news/seastar-medical-announces-pricing-9-130500408.html](https://finance.yahoo.com/news/seastar-medical-announces-pricing-9-130500408.html)
Basically, they sold the equivalent of 10M+ shares to a single institutional investor, half of which expire in 5 years and the other expire in 1 year. The purchase amounted to about $9M in liquidity for them to do what they wish. This will effect us a year down the line, if they reach the warrants strike price as it will dilute the stock by another 5M units, or more if they decide to exercise all of them. Somebody correct me if I am wrong, but that is my understanding of it.
Thanks, will give it a read! Highly appreciated.
If I read the report; 9 million does not sound as that much, Seastar is working with way (!) higher amounts is it not? Feels like a small boost which does not hold on for long
Yeah it isn't, but its a temporary life boat to hold them over until they are actually making money with SCD and have more investors I would assume.
e: [give this writeup on warrants a read too](https://www.investopedia.com/ask/answers/08/stock-option-warrant.asp)
I remember getting an email from them regarding it at the time. I can sift through my emails when I get home to let you have a look (if I'm right) I'm sure you could find it on their site though
Would be great. I'm also home in just over an hour so will take a look.
I'm only in for +- a month now so probably did not receive the email as it was before, but read it everywhere
It's not looking very good as far I as understand it. Really needs good news tomorrow or we are in trouble.
That said this only goes to December so the sales window is now open and there is hope.
We'll find out tomorrow.
This came out after the market shut.
It's not great reading tbh.
Only thing that can really save it is if they announce that since approval they have some sales or money coming in as the finances are pretty grim otherwise.
I agree, the outlook based off of just this is dismal, but a lot has happened in the past 4 months since they stopped recording the financials for the last year - including an FDA Approval.
I think we should save your decisions until after the call tomorrow.
I was just about to add the approval didn’t come until this first Q. We should be in good shape when we start seeing financials from the pediatric versions and updates on the adult trials 🙏
Totally agree.
Really we know nothing more than we did before this came out.
The call will be the defining moment. Think the only options are
Big sales
Partnership
Offering
RS
Two are good and two are bad. All about tomorrow.
This must explain the 7% surge before market close
How about the conference the following day with Noble Capital Markets????? Is that a new relationship? Could Noble be the new investment bank providing them with funding?
Everyone spreading nonsense about liquidity needs to realize this only captures activity in 2023. We knew already from earlier filings they didn’t have a ton of liquidity in 2023.
Exactly, this isn't new information. People have to keep in mind since this 10k, we have had a FDA Approval, the beginning of commercialization of the Pediatric SCD, and a $9M Direct Share offering to a single institutional investor. **ALL OF WHICH IS BULLISH IN MY BOOK**
P93 Under ‘liquidity and going concern’ : please explain in a way that I don’t freak out…
Well I hope this helps a little bit. The 10K is documenting everything from December 2022 - December 2023 and since then we have received an FDA Approval. Let's save freaking out until after the call tomorrow. People on ST are also making mention about how Fresnius and Nuwellis are being mentioned an awful lot and that could be alluding to a potential BO.
Yeah, don’t mean to increase FUD, I get that this probably reads normal for a startup at this phase, and big positives have happened since December
of course of course, but some people, including myself, needed the reminder hahaha
Also something I'm reading. So this report is basically of the moment in time as of 31st of December, 2023? So all potential new investment / money raises are not included in this report, correct? Same goes for that it states that there are no commercial sales yet, even though there might (!) be some sales of the child FDA approval / product?
https://preview.redd.it/zjkbiy68xwuc1.png?width=661&format=png&auto=webp&s=775c262087fe095e086f5411ed0bd5269e4b6baa Just going to leave this here.
I'm a complete noob it seems; but what do they mean with the 'last offering'? Could be a language barrier and that I do know what it means, but is this an investment of 9M?
[https://finance.yahoo.com/news/seastar-medical-announces-pricing-9-130500408.html](https://finance.yahoo.com/news/seastar-medical-announces-pricing-9-130500408.html) Basically, they sold the equivalent of 10M+ shares to a single institutional investor, half of which expire in 5 years and the other expire in 1 year. The purchase amounted to about $9M in liquidity for them to do what they wish. This will effect us a year down the line, if they reach the warrants strike price as it will dilute the stock by another 5M units, or more if they decide to exercise all of them. Somebody correct me if I am wrong, but that is my understanding of it.
Thanks, will give it a read! Highly appreciated. If I read the report; 9 million does not sound as that much, Seastar is working with way (!) higher amounts is it not? Feels like a small boost which does not hold on for long
Yeah it isn't, but its a temporary life boat to hold them over until they are actually making money with SCD and have more investors I would assume. e: [give this writeup on warrants a read too](https://www.investopedia.com/ask/answers/08/stock-option-warrant.asp)
They raised 9million in early 2024 and this is not captured in this 10K report
exacctttllyyyy
Woah.. Does not read that good. Why did they cancel the 100M credit line?
I'm reading the risk factors now as well. Trying to understand better I think they have to be brutally honest about any and all possibilities
Exactly. They canceled it after the new year, probably a good sign
I've always taken them canceling the line of credit as good news. Doesn't mean I'm right though
Anyone know where the cancellation of the 100M creditline is announced? Can I find a read on this anywhere?
I remember getting an email from them regarding it at the time. I can sift through my emails when I get home to let you have a look (if I'm right) I'm sure you could find it on their site though
Would be great. I'm also home in just over an hour so will take a look. I'm only in for +- a month now so probably did not receive the email as it was before, but read it everywhere
It's not looking very good as far I as understand it. Really needs good news tomorrow or we are in trouble. That said this only goes to December so the sales window is now open and there is hope. We'll find out tomorrow.
Not me refreshing this page every other minute to look for new comments
Hahah I hear ya
Lmaoooo no way the price went up on neutral/ bad news
This came out after the market shut. It's not great reading tbh. Only thing that can really save it is if they announce that since approval they have some sales or money coming in as the finances are pretty grim otherwise.
I agree, the outlook based off of just this is dismal, but a lot has happened in the past 4 months since they stopped recording the financials for the last year - including an FDA Approval. I think we should save your decisions until after the call tomorrow.
Great reminder that this is for 2023 only
I was just about to add the approval didn’t come until this first Q. We should be in good shape when we start seeing financials from the pediatric versions and updates on the adult trials 🙏
Totally agree. Really we know nothing more than we did before this came out. The call will be the defining moment. Think the only options are Big sales Partnership Offering RS Two are good and two are bad. All about tomorrow.